Angela Riccobon

924 total citations
44 papers, 707 citations indexed

About

Angela Riccobon is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Angela Riccobon has authored 44 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 24 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Angela Riccobon's work include Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (12 papers) and vaccines and immunoinformatics approaches (12 papers). Angela Riccobon is often cited by papers focused on Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (12 papers) and vaccines and immunoinformatics approaches (12 papers). Angela Riccobon collaborates with scholars based in Italy, United States and Netherlands. Angela Riccobon's co-authors include Ruggero Ridolfi, Laura Ridolfi, Massimiliano Petrini, Laura Fiammenghi, Emanuela Flamini, Emanuela Scarpi, Oriana Nanni, Dino Amadori, Anna Maria Granato and D. Amadori and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Angela Riccobon

44 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Riccobon Italy 16 409 392 236 94 59 44 707
Benjamin Toh Singapore 7 493 1.2× 441 1.1× 203 0.9× 134 1.4× 23 0.4× 10 854
Rodwell Mabaera United States 14 299 0.7× 391 1.0× 256 1.1× 66 0.7× 59 1.0× 20 827
Suzanne Fioravanti United States 12 452 1.1× 261 0.7× 146 0.6× 62 0.7× 32 0.5× 28 696
Christine Kerr Canada 13 254 0.6× 230 0.6× 226 1.0× 43 0.5× 67 1.1× 18 596
Elvira Avilla Italy 6 227 0.6× 322 0.8× 212 0.9× 58 0.6× 34 0.6× 6 640
Heather L. Machado United States 14 340 0.8× 282 0.7× 249 1.1× 94 1.0× 41 0.7× 22 612
M. Numasaki Japan 3 342 0.8× 518 1.3× 114 0.5× 59 0.6× 31 0.5× 5 695
Maxim Kebenko Germany 12 265 0.6× 165 0.4× 243 1.0× 43 0.5× 41 0.7× 30 609
Sophia Bornstein United States 9 433 1.1× 275 0.7× 441 1.9× 166 1.8× 13 0.2× 17 819
Alexander Martens Germany 14 503 1.2× 530 1.4× 181 0.8× 43 0.5× 49 0.8× 22 787

Countries citing papers authored by Angela Riccobon

Since Specialization
Citations

This map shows the geographic impact of Angela Riccobon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Riccobon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Riccobon more than expected).

Fields of papers citing papers by Angela Riccobon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Riccobon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Riccobon. The network helps show where Angela Riccobon may publish in the future.

Co-authorship network of co-authors of Angela Riccobon

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Riccobon. A scholar is included among the top collaborators of Angela Riccobon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Riccobon. Angela Riccobon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ridolfi, Laura, Massimiliano Petrini, Anna Maria Granato, et al.. (2013). Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients. Journal of Translational Medicine. 11(1). 135–135. 58 indexed citations
4.
Ridolfi, Laura, Massimiliano Petrini, Laura Fiammenghi, et al.. (2010). Unexpected High Response Rate to Traditional Therapy after Dendritic Cell‐Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis. Journal of Immunology Research. 2010(1). 15 indexed citations
5.
Ridolfi, Laura, Massimiliano Petrini, Laura Fiammenghi, Angela Riccobon, & Ruggero Ridolfi. (2008). Human embryo immune escape mechanisms rediscovered by the tumor. Immunobiology. 214(1). 61–76. 18 indexed citations
6.
Ridolfi, Ruggero, Laura Ridolfi, Massimiliano Petrini, et al.. (2007). P-22 Dendritic cell vaccination induces longer overall survival in immunoreactive advanced melanoma patients. Melanoma Research. 17(1). A26–A27. 1 indexed citations
7.
Guida, Michele, Angela Riccobon, Guido Biasco, et al.. (2006). Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma. Melanoma Research. 16(4). 317–323. 7 indexed citations
8.
Riccobon, Angela, Roberta Gunelli, Ruggero Ridolfi, et al.. (2004). Immunosuppression in Renal Cancer: Differential Expression of Signal Transduction Molecules in Tumor-Infiltrating, Near-Tumor Tissue, and Peripheral Blood Lymphocytes. Cancer Investigation. 22(6). 871–877. 16 indexed citations
9.
Ridolfi, Ruggero, Angela Riccobon, Riccardo Galassi, et al.. (2004). Evaluation of in vivo labelled dendritic cell migration in cancer patients. Journal of Translational Medicine. 2(1). 27–27. 100 indexed citations
10.
Gardini, Andrea, Giorgio Ercolani, Angela Riccobon, et al.. (2004). Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin‐2 after radical hepatic resection for colorectal liver metastases: 5‐year analysis. Journal of Surgical Oncology. 87(1). 46–52. 36 indexed citations
11.
Ridolfi, Laura, Ruggero Ridolfi, Angela Riccobon, et al.. (2003). Adjuvant Immunotherapy With Tumor Infiltrating Lymphocytes and Interleukin-2 in Patients With Resected Stage III and IV Melanoma. Journal of Immunotherapy. 26(2). 156–162. 17 indexed citations
12.
Ridolfi, Ruggero, Laura Ridolfi, Massimiliano Petrini, Laura Fiammenghi, & Angela Riccobon. (2003). Dendritic cell vaccination and immunostimulation in advanced melanoma. Expert Review of Vaccines. 2(6). 825–833. 4 indexed citations
13.
Ridolfi, Ruggero, Angela Riccobon, Emanuela Flamini, et al.. (2003). Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2. British Journal of Cancer. 88(2). 320–326. 26 indexed citations
14.
Medri, Laura, Oriana Nanni, Annalisa Volpi, et al.. (2002). L'angiogenesi nel carcinoma della mammella. 7(3). 185–189. 1 indexed citations
15.
Susino, M. Dal, Annalisa Volpi, D. Amadori, et al.. (2000). Comparison between differentcell kinetic variables in human breast cancer. Cell Proliferation. 33(2). 75–89. 14 indexed citations
16.
Medri, Laura, Oriana Nanni, Annalisa Volpi, et al.. (2000). Tumor microvessel density and prognosis in node-negative breast cancer. International Journal of Cancer. 89(1). 74–80. 35 indexed citations
17.
18.
Ridolfi, Ruggero, Roberta Maltoni, Angela Riccobon, et al.. (1994). A Phase II Study of Advanced Colorectal Cancer Patients Treated with Combination 5-Fluorouracil Plus Leucovorin and Subcutaneous Interleukin-2 Plus Alpha Interferon. Journal of Chemotherapy. 6(4). 265–271. 5 indexed citations
19.
Gion, Massimo, Ruggero Dittadi, Antonette E. Leon, et al.. (1991). Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: A multicentre study. European Journal of Cancer and Clinical Oncology. 27(8). 996–1002. 5 indexed citations
20.
Zoli, Wainer, Annalisa Volpi, Chiara Bonaguri, et al.. (1991). An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activityin vitro: Experience on 136 primary cancers and on 116 recurrences. Breast Cancer Research and Treatment. 17(3). 231–238. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Toh Breakdown of academic impact, for papers by Rodwell Mabaera Breakdown of academic impact, for papers by Suzanne Fioravanti Breakdown of academic impact, for papers by Christine Kerr Breakdown of academic impact, for papers by Elvira Avilla Breakdown of academic impact, for papers by Heather L. Machado Breakdown of academic impact, for papers by M. Numasaki Breakdown of academic impact, for papers by Maxim Kebenko Breakdown of academic impact, for papers by Sophia Bornstein Breakdown of academic impact, for papers by Alexander Martens
Rankless by CCL
2026